These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 15660983)

  • 1. Rituximab for autoimmune haemophilia: a proposed treatment algorithm.
    Aggarwal A; Grewal R; Green RJ; Boggio L; Green D; Weksler BB; Wiestner A; Schechter GP
    Haemophilia; 2005 Jan; 11(1):13-9. PubMed ID: 15660983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rituximab for the treatment of patients with very high-titre acquired factor VIII inhibitors refractory to conventional chemotherapy.
    Field JJ; Fenske TS; Blinder MA
    Haemophilia; 2007 Jan; 13(1):46-50. PubMed ID: 17212724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acquired haemophilia: management of bleeds and immune therapy to eradicate autoantibodies.
    Holme PA; Brosstad F; Tjønnfjord GE
    Haemophilia; 2005 Sep; 11(5):510-5. PubMed ID: 16128896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Long-term response to rituximab in a patient with acquired hemophilia].
    García-Chávez J; Vela-Ojeda J; García-Manzano A; Majluf-Cruz A
    Rev Invest Clin; 2011; 63(2):210-2. PubMed ID: 21717725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rituximab as an adjuvant therapy to immune tolerance in a haemophilia A boy with high inhibitor titre.
    Chuansumrit A; Husapadol S; Wongwerawattanakoon P; Hongeng S; Sirachainan N; Pakakasama S
    Haemophilia; 2007 Jan; 13(1):108-10. PubMed ID: 17212736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acquired hemophilia in the patient suffering from rheumatoid arthritis: case report.
    Drobiecki A; Pasiarski M; Hus I; Sokołowska B; Wątek M
    Blood Coagul Fibrinolysis; 2013 Dec; 24(8):874-80. PubMed ID: 24042266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitor development and management in three non-severe haemophilia A patients with T295A variant.
    Ivaskevicius V; Goldmann G; Horneff S; Marquardt N; Klein C; Albert T; Zeitler H; Oldenburg J
    Hamostaseologie; 2014; 34 Suppl 1():S9-12. PubMed ID: 25382774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunosuppressive treatment of a spontaneous inhibitor hemophilia A using cyclophosphamide, vincristine and prednisone following prior Factor VIII stimulation].
    Dürig J; de Wit M; Fiedler W; Marx G; Hossfeld DK
    Schweiz Med Wochenschr; 1996 Nov; 126(47):2026-31. PubMed ID: 8984611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rituximab in the treatment of acquired factor VIII inhibitors.
    Wiestner A; Cho HJ; Asch AS; Michelis MA; Zeller JA; Peerschke EI; Weksler BB; Schechter GP
    Blood; 2002 Nov; 100(9):3426-8. PubMed ID: 12384448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rituximab for adolescents with haemophilia and high titre inhibitors.
    Fox RA; Neufeld EJ; Bennett CM
    Haemophilia; 2006 May; 12(3):218-22. PubMed ID: 16643204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Durable responses to rituximab in acquired factor VIII deficiency.
    Singh AG; Hamarneh IS; Karwal MW; Lentz SR
    Thromb Haemost; 2011 Jul; 106(1):172-4. PubMed ID: 21544323
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibitor treatment by rituximab in congenital haemophilia A - Two case reports.
    Streif W; Escuriola Ettingshausen C; Linde R; Kropshofer G; Zimmerhackl LB; Kreuz W
    Hamostaseologie; 2009 May; 29(2):151-4. PubMed ID: 19404522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acquired factor VIII inhibitors in non-haemophilic patients: clinical experience of 15 cases.
    Huang YW; Saidi P; Philipp C
    Haemophilia; 2004 Nov; 10(6):713-21. PubMed ID: 15569166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rituximab for treatment of inhibitors in haemophilia A. A Phase II study.
    Leissinger C; Josephson CD; Granger S; Konkle BA; Kruse-Jarres R; Ragni MV; Journeycake JM; Valentino L; Key NS; Gill JC; McCrae KR; Neufeld EJ; Manno C; Raffini L; Saxena K; Torres M; Marder V; Bennett CM; Assmann SF
    Thromb Haemost; 2014 Sep; 112(3):445-58. PubMed ID: 24919980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Rituximab in the treatment of acquired haemophilia A in a patient with polymyalgia rheumatica].
    Braunert L; Bruegel M; Pfrepper C; Thiery J; Niederwieser D
    Hamostaseologie; 2010 Nov; 30 Suppl 1():S40-3. PubMed ID: 21042682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitor eradication with rituximab in haemophilia: where do we stand?
    Franchini M; Mannucci PM
    Br J Haematol; 2014 Jun; 165(5):600-8. PubMed ID: 24628543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune tolerance with rituximab in congenital haemophilia with inhibitors: a systematic literature review based on individual patients' analysis.
    Franchini M; Mengoli C; Lippi G; Targher G; Montagnana M; Salvagno GL; Zaffanello M; Cruciani M
    Haemophilia; 2008 Sep; 14(5):903-12. PubMed ID: 18671801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment with rituximab in an elderly patient with acquired factor VIII inhibitor.
    Cretel E; Jean R; Chiche L; Durand JM
    Geriatr Gerontol Int; 2009 Jun; 9(2):197-9. PubMed ID: 19490140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of refractory autoimmune (acquired) haemophilia with anti-CD20 (rituximab).
    Kain S; Copeland TS; Leahy MF
    Br J Haematol; 2002 Nov; 119(2):578. PubMed ID: 12406107
    [No Abstract]   [Full Text] [Related]  

  • 20. Successful response to rituximab in two cases of acquired haemophilia refractory to standard-therapy.
    Machado P; Raya JM; Martín T; Morabito L; Brito ML; Rodríguez-Martín JM
    Int J Hematol; 2008 Jun; 87(5):545-549. PubMed ID: 18414981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.